Experimental investigations utilizing viral‐transduced and transgenic mouse models have provided evidence that replication of tau acetylation at distinct sites elicits AD‐like phenotypes, such as synaptic dysfunction, neuronal degeneration, and cognitive deficits. The gene discussed is MAPT; the disease is Alzheimer disease.